» Articles » PMID: 30987674

Association Between Baseline Clinical and Imaging Findings and the Development of Digital Ulcers in Patients with Systemic Sclerosis

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2019 Apr 17
PMID 30987674
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Systemic sclerosis (SSc) can lead to ischemic complications such as digital ulcers (DUs). The aim of the study was to find predictors of DUs by clinical and new imaging methods.

Patients And Methods: All 79 SSc patients included in the study received a clinical, colour Doppler ultrasound (CDUS), fluorescence optical imaging (FOI) and capillaroscopy examination at baseline, and their capacity to predict new DU development was analysed in 76 patients at 12 months follow-up.

Results: Twenty-two of 76 patients (28.9%) developed new ulcers during follow-up (diffuse SSc 48.1%; limited SSc 18.4%). Receiver operating characteristic (ROC) curve analysis revealed an area under the curve of 0.7576 for DU development, with a specificity of 87% and a sensitivity of 54.6% (p = 0.0003, OR = 8.1 [95%CI 2.5-25.6]) at a cut-off of ≥ 21 points (ACR/EULAR classification criteria for SSc). Capillaroscopy and CDUS had high sensitivity (100% and 95.5%) but low specificity (28.9% and 22.2%) for ulcer occurrence when used alone, but better specificity (46.3%) when combined (OR = 18.1 [95%CI 2.3-144.4]; p = 0.0004). Using FOI, fingers with pathologic staining had a higher risk for new ulcer development in the same finger (p = 0.0153). General future DU (i.e. DU also in other fingers) was associated with a missing FOI signal in the right digit III at baseline (p = 0.048).

Conclusion: New imaging modalities can predict digital ulcer development in SSc patients with high sensitivity for capillaroscopy and CDUS and enhanced specificity when combined. A missing signal of FOI in the right digit III at baseline was associated with general future DU.

Citing Articles

Metabolic and molecular imaging in inflammatory arthritis.

Noversa de Sousa R, Tascilar K, Corte G, Atzinger A, Minopoulou I, Ohrndorf S RMD Open. 2024; 10(1).

PMID: 38341194 PMC: 10862311. DOI: 10.1136/rmdopen-2023-003880.


Fluorescence optical imaging feature selection with machine learning for differential diagnosis of selected rheumatic diseases.

Rothe F, Berger J, Welker P, Fiebelkorn R, Kupper S, Kiesel D Front Med (Lausanne). 2023; 10:1228833.

PMID: 37671403 PMC: 10475553. DOI: 10.3389/fmed.2023.1228833.


[Can rheuma be scanned? : Review of the current study situation on fluorescence optical imaging].

Werner S, Backhaus M, Ohrndorf S Z Rheumatol. 2023; 82(8):627-637.

PMID: 37626223 DOI: 10.1007/s00393-023-01404-8.


Features Found in Indocyanine Green-Based Fluorescence Optical Imaging of Inflammatory Diseases of the Hands.

Gedat E, Berger J, Kiesel D, Failli V, Briel A, Welker P Diagnostics (Basel). 2022; 12(8).

PMID: 35892489 PMC: 9331249. DOI: 10.3390/diagnostics12081775.


Fluorescence optical imaging: ready for prime time?.

Ohrndorf S, Glimm A, Ammitzboll-Danielsen M, Ostergaard M, Burmester G RMD Open. 2021; 7(2).

PMID: 34088778 PMC: 8183208. DOI: 10.1136/rmdopen-2020-001497.


References
1.
Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E . Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis. 2012; 71(10):1636-9. DOI: 10.1136/annrheumdis-2011-200780. View

2.
Frerix M, Meier F, Muller-Ladner U . [The road to early diagnosis of systemic sclerosis : the evolution of diagnostic and classification criteria in the past decades]. Z Rheumatol. 2013; 72(10):954-9. DOI: 10.1007/s00393-013-1194-x. View

3.
Legany N, Toldi G, Distler J, Beyer C, Szalay B, Kovacs L . Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis. Clin Chem Lab Med. 2015; 53(11):1799-805. DOI: 10.1515/cclm-2015-0079. View

4.
Wirz E, Jaeger V, Allanore Y, Riemekasten G, Hachulla E, Distler O . Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann Rheum Dis. 2015; 75(7):1285-92. DOI: 10.1136/annrheumdis-2015-207271. View

5.
LeRoy E, Medsger Jr T . Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001; 28(7):1573-6. View